Lipocine Inc. announced that Morgan Brown has joined the company as Executive Vice President and Chief Financial Officer. Most recently, Mr. Brown was the CFO at Innovus Pharmaceuticals Inc. Mr. Brown has more than 20 years of financial and accounting experience, including over 13 years in financial management of life science companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.18 USD | -32.83% |
|
-9.69% | +157.35% |
Jun. 10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+157.35% | 38.4M | |
+14.84% | 121B | |
+18.31% | 112B | |
+3.61% | 22.57B | |
-18.26% | 20.82B | |
-17.24% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Lipocine Inc. Appoints Morgan Brown as Executive Vice President and Chief Financial Officer